Vaccinating against flagellin, a protein involved in the movement of certain bacteria, lessened inflammation in the gut, a study of mice shows. These findings suggest that vaccination against certain ... Read more

This time last year, I became a Kyo Sa Nim, a second-degree black belt in the Korean martial art Mu Sool Won. A first-degree black belt usually trains for ... Read more

The U.S. Food and Drug Administration (FDA) has approved Pfizer‘s extended-release tablets of Xeljanz XR (tofacitinib) to treat adults with moderately to severely active ulcerative colitis. This approval of 11 ... Read more

The U.S. Food and Drug Administration (FDA) has approved Amgen’s Avsola (infliximab-axxq) — a biosimilar to Janssen’s Remicade (infliximab) — to treat adults and children with moderate-to-severe Crohn’s disease ... Read more

This past week or so, I have been plagued by a nasty cold. My sickness got me thinking about cold and flu season with Crohn’s disease and IBD. Most ... Read more

About six months ago, I reconnected with my childhood best friend, Suzanne, after losing contact with her more than 15 years ago. We had been very close since meeting ... Read more

A new formulation of CT-P13, a biosimilar of Remicade (infliximab), that is given as an under-the-skin (subcutaneous) injection, was shown to be as safe and effective in treating inflammatory bowel ... Read more

Engitix and Morphic Therapeutic announced the start of a research partnership into extracellular matrix targets for treating inflammatory bowel disease (IBD) with intestinal fibrosis, known as fibrostenotic IBD. The extracellular ... Read more

Crohn’s and Colitis Awareness Week took place last week. Though Crohn’s disease and ulcerative colitis — collectively known as inflammatory bowel disease (IBD) — affect more than three million ... Read more

The membrane type 1-matrix metalloproteinase (MT1-MMP) protein may be a promising therapeutic target for inflammatory bowel disease (IBD) — possibly targeting the disease in its early stages, a study ... Read more